Impact of Travel Distance to Treatment Institution on Survival from Stage I to III Lung Cancer
C. Da Silva, G. Werutsky, A. Gelatti, M.T. Ruiz Tsukazan, G. Lenz, V. Sgnaolin,M. Rosa, R. D'Avila, P.R. Nunes Filho, P. Pacheco, J. Figueiredo Pinto, J. Rios,M.H. Sostruznik, F. Zaffaroni, A. Poisl Fay. 18th World Conference on Lung Cancer - IASLC Full link: https://www.jto.org/article/S1556-0864(17)32575-3/abstract
Are the Real World Patients with Advanced Non-Small Cell Lung Cancer Represented in Phase III Immunotherapy Trials?
J. Cé Coelho, T. Rebelato, A. Gelatti, R. D'Avila, G. Geib, P. Rubini Liedke,R. Peres Pereira, G. Werutsky, S. Jobim De Azevedo. 18th World Conference on Lung Cancer IASLC Full link: https://www.jto.org/article/S1556-0864(17)31452-1/fulltext
Molecular testing for non-small cell lung cancer in Latin America
J. Cé Coelho, A. Gelatti, F. Caorsi, C. Mathias, G. Werutsky. 18th World Conference on Lung Cancer - IASLC Full link: https://www.jto.org/article/S1556-0864(17)31432-6/fulltext
Real-world data evaluating the value of PET-CT for mediastinal staging in patients diagnosed with non-small cell lung cancer in an area with high prevalence of granulomatous diseases: The LACOG-0114 study.
Carlos Cezar Fritscher, Mara Lise Zanini, Eduardo Herz Berdichevski, Eduardo Vilas, Bruno Hochhegger, Vinicius Duval da Silva, José Antônio Figueiredo Pinto, Leandro Genehr Fritscher, Louise Hartmann, Marcos Alba, Guilherme Parisotto Sartori, Cristina Matushita, Arthur Vieira, Vanessa Rezende Bortolotto, Rayssa Ruszkowski do Amaral, Facundo Zaffaroni, Jeovany Martínez-Mesa, Gustavo Werutsky, Carlos H. Barrios, Marcio Debiasi ASCO 2017 Full link: https://meetinglibrary.asco.org/record/148388/abstract
Dual time PET-CT for mediastinal nodal staging in patients diagnosed with non-small cell lung cancer in an area with high prevalence of infectious granulomatous disease (LACOG-0114).
Bruno Hochhegger, Maria Teresa Ruiz Tsukazan, Vanessa Rezende Bortolotto, Arthur Vieira, Carlos Cezar Fritscher, Mara Lise Zanini, Eduardo Herz Berdichevski, Eduardo Vilas, Vinicius Duval da Silva, José Antônio Lopes de Figueiredo Pinto, Leandro Genehr Fritscher, Louise Hartmann, Marcos Alba, Airton Schneider, Marcio Debiasi, Facundo Zaffaroni, Jeovany Martínez-Mesa, Carlos H. Barrios, Gustavo Werutsky ASCO 2017 Full link: https://meetinglibrary.asco.org/record/148248/abstract
Consolidation chemotherapy following concurrent chemoradiation for stage III non-small cell lung cancer: a brazilian multicentric cohort
Vladmir Cordeiro de Lima, Clarissa Baldotto, Carlos Barrios, Eldsamira Sobrinho, Mauro Zukin, Clarissa Mathias, Facundo Zaffaroni, Rodrigo Nery, Gabriel Madeira, Alex Amadio, Guilherme Geib, Juliano Coelho, Maria Fernanda Simões, Gilberto De Castro JrJournal of Thoracic Oncology , Volume 12 , Issue 1 , S865 - S866 Full link: https://www.jto.org/article/S1556-0864(16)32418-2/fulltext
Updated Analysis of Global Epidemiology of EGFR Mutation in Advanced Non-Small Cell Lung Cancer
IASLC 7th Latin American Conference on Lung CancerGustavo Werutsky, Marcio Debiasi, Fernanda H. Sampaio, Paulo R. Nunes Filho, Clarissa Mathias, Mauro Zukin, Facundo Zaffaroni, Gilberto LopesJournal of Thoracic Oncology , Volume 11 , Issue 10 , S184 - S185 Full link: https://www.jto.org/article/S1556-0864(16)30739-0/fulltext
Impact of Regulatory Delays in Drug Approval: Mortality and Morbidity Due to With Lack of Access to Crizotinib in Brazil
Pablo Moura Barrios, Marcio Debiasi, Gilberto Lopes, Carlos H. BarriosOctober 2016 Volume 11, Issue 10, Supplement, Page S215 Full link: https://www.jto.org/article/S1556-0864(16)30782-1/fulltext